implanted device (cardiology)

3-Year SMART-CHOICE Results Support Aspirin Discontinuation After PCI

3-Year SMART-CHOICE Results Support Aspirin Discontinuation After PCI

Shortening the duration of dual antiplatelet therapy (DAPT) and continuing a P2Y12 inhibitor alone after percutaneous coronary intervention (PCI) was associated with a similar rate of ischemic events but with less bleeding than prolonged DAPT after 3 years of follow-up in the SMART -CHOICE trial. “Current results from the extended follow-up of the SMART-CHOICE trial …

3-Year SMART-CHOICE Results Support Aspirin Discontinuation After PCI Read More »

Pulmonary artery denervation takes another step in hypertension

Pulmonary artery denervation takes another step in hypertension

Pulmonary Artery Denervation (PADN) Combined with a Phosphodiesterase-5 Inhibitor Improved Exercise Capacity, Cardiac Function, and Some Clinical Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) in a Controlled Trial fictitious. The primary endpoint of change from baseline in 6-minute walking distance increased in both groups at 30 days, with a median change at 6 months …

Pulmonary artery denervation takes another step in hypertension Read More »